Skip to content

Medical Arts Health Research Group collaborates with Interior Health to advance access to Crohn’s disease research

Kelowna, B.C. – Medical Arts Health Research Group, a leading health-care research organization, and Interior Health (IH) are pleased to announce a collaboration for a clinical research study focused on the treatment of Crohn’s disease.

Before, patients within the B.C. Interior have had to travel to a major city such as Vancouver to access new treatment options. This collaboration makes these treatments available to individuals in Kelowna and other B.C. residents.

“We are looking forward to being able to provide direct access to these therapies right here in our community,” said Dr. Donna Benson, founder of Medical Arts Health Research Group. “It often takes an extensive 17 years for a proven treatment to reach those who could potentially benefit. Clinical trials such as this serve as a vital avenue to accelerate access and provide hope for patients in need.”

The study will be looking at a new treatment for patients with moderately to severely active Crohn’s disease. Many patients do not respond adequately to existing therapies, and this new research will aim to address this unmet medical need.

Key Highlights:

  • Collaboration: Medical Arts Health Research Group and IH are pooling their resources to advance Crohn’s disease research in the Okanagan. IH will be providing services that include access to facilities, as well as physician and nurse support.
  • Innovative Treatment: A new innovative treatment for inflammatory bowel disease has shown promising results in previous studies, and this joint effort aims to further evaluate its potential.
  • Patient Impact: The study aims to improve the quality of life for individuals living with Crohn’s disease by identifying and expanding on the effective treatment options available for inflammatory bowel disease.

“We are excited about this partnership and how it will support patient care in our region. Clinical research is one avenue to introduce new therapies and plays an important role of advancing care for patients. – Dr. Deanne Taylor, Corporate Director, Research, Interior Health Authority

“The value of building relationships with external researchers enhances the diversity and the volume of clinical research conducted within IH, creates more opportunities for participation, and improves patient care.” – Tess Topor, Leader, Clinical Research, Interior Health Authority

To learn more about the study, click here!